Summary

This report is an essential source for data, analysis and strategic insight into the medical equipment business of Sepracor Inc.. The report provides key information relating to Sepracor Inc.  medical equipment revenue, market share by sector and country, financial and SWOT analysis of the company. The report examines the medical equipment business structure and operations, history and products, and provides an analysis of its key medical equipment revenue lines. It inspects the company's strategic strengths and weaknesses.

Scope

-Revenues for the medical equipment markets and sub-sectors by country and region.
-Provides the share of market and sub sectors by country and region.
-Detailed breakdown revenues contributed by the medical equipment business operations.
-Provides summary of the medical equipment pipeline products that the company is developing.
-Critical analysis of the company's strengths, weaknesses opportunities and threats.
-Provides summary analysis of key revenue lines and strategy.
-Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
-Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
-Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

-A single source to fulfill all of your business and competitor intelligence needs
-Research your competitor's business structure, strategy and prospects.
-Counter your competitor's strengths and target their weaknesses.
-Identify your competitor's key revenue streams by market and geography.
-Identify and assess potential corporate and investment opportunities.
-Support sales activities by understanding your customers businesses better.
-Identify potential competitor products before they reach market.
-Qualify prospective partners and suppliers.

Table of Contents

1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
3 Definitions of Markets/Categories Covered 8
3.1 Drug Delivery Devices 8
3.1.1 Inhalation Systems 8
4 Company Snapshot 9
4.1 Key Information 9
4.2 Company Overview 9
4.3 Financial Performance 9
4.4 SWOT Snapshot 9
4.5 Business Overview 10
4.6 Major Products and Services 11
4.6.1 Overview 11
5 History 12
6 SWOT Analysis 13
6.1 Overview 13
6.2 Sepracor Inc. Strengths 13
6.2.1 Improved Revenues 13
6.2.2 Research and Development 14
6.2.3 Expanding Market Share in Sector 14
6.2.4 Efficient Use of Resources 14
6.3 Sepracor Inc. Weaknesses 14
6.3.1 Dependency on Third Party Manufacturers 14
6.3.2 High Dependency on Certain Products 14
6.3.3 Limited Operating Margin 15
6.3.4 Limited Liquidity Position 15
6.3.5 Limited Investor Confidence 15
6.4 Sepracor Inc. Opportunities 15
6.4.1 Emerging Markets 15
6.4.2 Rising Healthcare Expenditure in the US 15
6.4.3 Agreements with Arrow International 15
6.4.4 Pharmaceutical Pipeline 16
6.4.5 Acquisition of Oryx Pharmaceuticals Inc. 16
6.5 Sepracor Inc. Threats 16
6.5.1 High Competitive Environment 16
6.5.2 Product Liability Claims 16
6.5.3 Tightening of the FDA's Regulatory Oversight 17
6.5.4 Industry Consolidation 17
7 Competitors 18
8 Sepracor Inc. Medical Equipment Market Share Analysis 19
8.1 Sepracor Inc., Drug Delivery Devices, Global, Market Share (2008) 19
8.2 Sepracor Inc., North America, Market Share (2008) 20
9 Key Employees 21
10 Key Employee Biographies 22
11 Company Statement 23
12 Locations And Subsidiaries 25
12.1 Head Office 25
12.2 Other Locations & Subsidiaries 25
13 Recent Developments 26
13.1 Strategy and Business Planning 26
13.1.1 Jan 28, 2009: Sepracor Announces Workforce Reduction Plan 26
13.2 Financial Announcements 26
13.2.1 Apr 30, 2009: Sepracor Posts $35.2 Million Profit For Q1 2009 26
13.2.2 Jan 28, 2009: Sepracor Reports 2008 Results 27
13.2.3 Jan 23, 2009: Sepracor To Report 2008 Results 28
13.3 Other Significant Developments 28
13.3.1 Jul 01, 2009: Sepracor Provides Update On Clinical Trials For SEP-225289, Lunesta 28
14 Appendix 29
14.1 Research Methodology 30
14.2 Secondary Research 31
14.3 Primary Research 31
14.4 Models 32
14.5 Forecasts 32
14.6 Expert Panels 32
14.7  Consulting 33
14.8 Contact Us 33
14.9 Disclaimer 33

1.1 List of Tables
Table 1:Sepracor Inc., Key Facts, 2009 9
Table 2:Sepracor Inc., SWOT Analysis, 2008 13
Table 3:Sepracor Inc., Drug Delivery Devices, Inhalation Systems, Global, Revenue ($ mn) and Market Share (%), 2008 19
Table 4:Sepracor Inc., Drug Delivery Devices, Inhalation Systems, North America, Revenue ($ mn) and Market Share (%), 2008 20
Table 5:Sepracor Inc., Key Employees 21
Table 6:Sepracor Inc., Subsidiaries 25

1.2 List of Figures
Figure 1:Sepracor Inc., Drug Delivery Devices, Inhalation Systems, North America, Market Share (%), 2008 20
Figure 2:  Methodology 30